Most Recent

image: The 2015 Salary Survey Is Complete

The 2015 Salary Survey Is Complete

By | March 13, 2015

Thanks to everyone who participated in this year's survey. Please check back in November for the results.

0 Comments

image: Rate Your Workplace Today!

Rate Your Workplace Today!

By | November 9, 2012

Only two weeks left to participate in The Scientist’s 2013 survey for best place to work in the life sciences.

0 Comments

image: Life Sciences Salary Survey 2012

Life Sciences Salary Survey 2012

By | November 1, 2012

Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.

2 Comments

image: Best Places to Work Academia, 2012

Best Places to Work Academia, 2012

By | August 1, 2012

On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.

0 Comments

image: Thank You for Taking our Survey!

Thank You for Taking our Survey!

By | September 12, 2011

Thank you for completing this year's Best Places to Work Survey. 

0 Comments

image: Last Day for Salary Survey

Last Day for Salary Survey

By | June 26, 2011

Today is your last chance to participate in our 2011 survey of life science salaries.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham